IPSC
Price
$0.58
Change
+$0.02 (+3.57%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
50.41M
29 days until earnings call
SCPH
Price
$5.67
Change
-$0.00 (-0.00%)
Updated
Oct 6 closing price
Capitalization
304.36M
28 days until earnings call
Interact to see
Advertisement

IPSC vs SCPH

Header iconIPSC vs SCPH Comparison
Open Charts IPSC vs SCPHBanner chart's image
Century Therapeutics
Price$0.58
Change+$0.02 (+3.57%)
Volume$1.15K
Capitalization50.41M
scPharmaceuticals
Price$5.67
Change-$0.00 (-0.00%)
Volume$10.9M
Capitalization304.36M
IPSC vs SCPH Comparison Chart in %
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. SCPH commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a StrongBuy and SCPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (IPSC: $0.56 vs. SCPH: $5.67)
Brand notoriety: IPSC and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 207% vs. SCPH: 515%
Market capitalization -- IPSC: $50.41M vs. SCPH: $304.36M
IPSC [@Biotechnology] is valued at $50.41M. SCPH’s [@Biotechnology] market capitalization is $304.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, SCPH is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 3 bullish TA indicator(s).

  • IPSC’s TA Score: 4 bullish, 5 bearish.
  • SCPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both IPSC and SCPH are a bad buy in the short-term.

Price Growth

IPSC (@Biotechnology) experienced а +12.17% price change this week, while SCPH (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

IPSC is expected to report earnings on Nov 06, 2025.

SCPH is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($304M) has a higher market cap than IPSC($50.4M). SCPH YTD gains are higher at: 60.169 vs. IPSC (-44.693). IPSC has higher annual earnings (EBITDA): -6.16M vs. SCPH (-85.55M). IPSC has more cash in the bank: 156M vs. SCPH (40.8M). IPSC (51.5M) and SCPH (52.4M) have identical debt. IPSC has higher revenues than SCPH: IPSC (114M) vs SCPH (50M).
IPSCSCPHIPSC / SCPH
Capitalization50.4M304M17%
EBITDA-6.16M-85.55M7%
Gain YTD-44.69360.169-74%
P/E RatioN/AN/A-
Revenue114M50M228%
Total Cash156M40.8M382%
Total Debt51.5M52.4M98%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCSCPH
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MA579.841.03
+0.18%
Mastercard
AL63.66-0.03
-0.05%
Air Lease Corp
EVO3.92-0.07
-1.75%
Evotec SE
NVEC66.90-1.58
-2.31%
NVE Corp
IMG0.24-0.01
-4.61%
CIMG Inc

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with AUTL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
N/A
AUTL - SCPH
41%
Loosely correlated
-4.49%
IPSC - SCPH
39%
Loosely correlated
+0.59%
ATAI - SCPH
39%
Loosely correlated
+1.28%
AURA - SCPH
39%
Loosely correlated
-2.70%
OCUL - SCPH
38%
Loosely correlated
+5.01%
More